Novartis UK has been recognized for its “people-first” human resources (HR) practices by being officially certified as a 2019 Top Employer by the Top Employers Institute, the sixth consecutive year the company has been granted this status. Sandoz UK, a division of the Novartis Group, has also been certified as a 2019 Top Employer. The annual, international Top Employer award recognizes market-leading employers that provide exceptional employee conditions. Contributing to Novartis UK’s success this year was the launch of three new wellbeing initiatives: • the Ensemble program, which supports Novartis associates in the UK whose lives have been affected by cancer, whether they are facing cancer as an individual, caregiver or as a manager; • a mental health action plan, put in place across Novartis UK to break the stigma about mental health in the workplace; • the Energized for Life program, which encourages all Novartis employees to realize their full potential and be their “best self every day and everywhere”. The program concentrates on a new cultural aspiration to be inspired, curious and “unbossed”. Erica Cassin, HR Director at Novartis UK, commented: “This year we have placed huge focus on our employee wellbeing offering through the launch of UK-specific support hubs for associates affected by mental health challenges and cancer. I am extremely proud that these important initiatives have contributed to our Top Employer success, and that they help to ensure Novartis remains an employer of choice.” www.top-employers.com
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.